Drug Repurposing for Viral Infectious Diseases: How Far Are We?

Trends in Microbiology
Beatrice MercorelliArianna Loregian

Abstract

Despite the recent advances in controlling some viral pathogens, most viral infections still lack specific treatment. Indeed, the need for effective therapeutic strategies to combat 'old', emergent, and re-emergent viruses is not paralleled by the approval of new antivirals. In the past years, drug repurposing combined with innovative approaches for drug validation, and with appropriate animal models, significantly contributed to the identification of new antiviral molecules and targets for therapeutic intervention. In this review, we describe the main strategies of drug repurposing in antiviral discovery, discuss the most promising candidates that could be repurposed to treat viral infections, and analyze the possible caveats of this trendy strategy of drug discovery.

Citations

May 31, 2019·Viruses·Volker KinastEike Steinmann
Jan 21, 2020·Cancer Science·Takaaki MasudaKoshi Mimori
Apr 15, 2020·Antimicrobial Agents and Chemotherapy·Zachary J SandlerBryan C Mounce
May 14, 2020·Journal of Biomolecular Structure & Dynamics·Mohammad Mahdi Nejadi BabadaeiMojtaba Falahati
Jun 3, 2020·Antimicrobial Agents and Chemotherapy·Nicholas S EyreMichael R Beard
Aug 11, 2020·Archiv der Pharmazie·Kashyap K DubeyManisha Sharma
Aug 23, 2020·Nanomaterials·Sangiliyandi GurunathanHyuk Song
Jul 22, 2020·Antimicrobial Agents and Chemotherapy·Beatrice MercorelliArianna Loregian
Dec 21, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Bo-Min LvHong-Yu Zhang
Jun 28, 2019·Frontiers in Cellular and Infection Microbiology·Lucie PeyclitJean-Marc Rolain
Apr 22, 2020·Dermatologic Therapy·Paolo AmerioGiulio Gualdi
Oct 6, 2020·Colombia médica : CM·Vicente Benavides-Cordoba
Jan 29, 2019·Frontiers in Microbiology·Andrzej GórskiBeata Weber-Dąbrowska
Apr 12, 2019·Frontiers in Cellular and Infection Microbiology·Draginja RadosevicSanja Glisic
Aug 25, 2020·Current Treatment Options in Infectious Diseases·Amanda Makha BifaniRuklanthi de Alwis
Oct 1, 2020·BMC Endocrine Disorders·Flavio A Cadegiani
Aug 23, 2020·Genes·Roberto SpreaficoAmalio Telenti
Jun 11, 2019·Expert Opinion on Drug Discovery·María-Jesús Pérez-PérezEva-María Priego
Apr 25, 2020·Nanomaterials·Maria Chiara SportelliNicola Cioffi
Feb 12, 2020·Antibiotics·Olga PaciosMaria Tomás
Oct 13, 2020·Revista Brasileira De Farmacognosia : Orgão Oficial Da Sociedade Brasileira De Farmacognosia·Kazhila C Chinsembu
Oct 24, 2020·Journal of Biomolecular Structure & Dynamics·Rajesh GhoshSnehasis Chowdhuri
Aug 29, 2020·The Journal of Biological Chemistry·Sujayita RoyRavit Arav-Boger
Nov 17, 2020·International Journal of Biological Macromolecules·Vipul PanchalDileep Vasudevan
Oct 31, 2020·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Khalid El BairiSaid Afqir
Jan 23, 2021·Briefings in Bioinformatics·Akanksha RajputManoj Kumar
Nov 12, 2020·Current Treatment Options in Infectious Diseases·Amanda Makha BifaniRuklanthi de Alwis
Feb 2, 2021·Frontiers in Pharmacology·Juwairiah Remali, Wan Mohd Aizat
Feb 18, 2021·Expert Opinion on Investigational Drugs·Frederick HansenMichael A Jarvis
Feb 19, 2021·Proceedings of the National Academy of Sciences of the United States of America·Erol C VatanseverWenshe Ray Liu
Jan 21, 2021·Antimicrobial Agents and Chemotherapy·Shawn HerringStephen J Polyak
Mar 18, 2021·PloS One·Edgardo Galan-Vasquez, Ernesto Perez-Rueda
Mar 21, 2021·Nature Communications·Jean-Sélim DriouichAntoine Nougairède
Sep 21, 2020·International Journal of Biological Macromolecules·Md Sorwer Alam ParvezMohammad Jakir Hosen
Apr 4, 2021·Journal of Biomolecular Structure & Dynamics·Nandan KumarG Narahari Sastry

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01328925
NCT03395405

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

© 2022 Meta ULC. All rights reserved